Skylands Capital’s Biote Corp BTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-158,600
Closed -$528K 153
2025
Q1
$528K Sell
158,600
-900
-0.6% -$4.29K 0.08% 121
2024
Q4
$986K Sell
159,500
-39,000
-20% -$227K 0.14% 100
2024
Q3
$1.11M Buy
198,500
+37,655
+23% +$251K 0.15% 97
2024
Q2
$1.2M Buy
160,845
+42,729
+36% +$264K 0.17% 94
2024
Q1
$685K Buy
118,116
+49,600
+72% +$249K 0.09% 111
2023
Q4
$338K Sell
68,516
-126,884
-65% -$654K 0.05% 115
2023
Q3
$1M Sell
195,400
-59,506
-23% -$351K 0.15% 95
2023
Q2
$1.72M Buy
+254,906
New +$1.51M 0.25% 76

Other funds holding BTMD

Skylands Capital's BTMD Position: Q2 2025 in Review

Skylands Capital sold out of Biote Corp (BTMD) in Q2 2025, closing a stake of 158,600 shares — an estimated $528K sold.

Skylands Capital first reported a position in BTMD in Q2 2023 and held it in 8 quarters. The position peaked at $1.72M in Q2 2023. 97 funds tracked by Wall St. Rank hold BTMD as of Q2 2025.

  • Skylands Capital reported no remaining Biote Corp position as of Q2 2025 after selling out during the quarter.
  • Skylands Capital sold 158,600 Biote Corp shares in Q2 2025, an estimated $528K.
  • Skylands Capital first reported a position in Biote Corp in Q2 2023 and held it in 8 quarters.
  • Skylands Capital's Biote Corp position peaked at $1.72M in Q2 2023.
  • 97 funds tracked by Wall St. Rank held Biote Corp as of Q2 2025.

Based on Skylands Capital's 13F filing for Q2 2025, filed 8 Aug 2025.